Prevalence of Cardiac Amyloidosis Among Elderly Patients With Recent-Onset Atrial Fibrillation: The PREVAL-ATTR Study
Canadian Journal of Cardiology · 2025
DOI: 10.1016/j.cjca.2024.10.010 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Canadian Journal of Cardiology, 2025. Verfasst von Paloma Remior-Pérez und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Hospital Universitario Puerta de Hierro Majadahonda, IDIPHISA, Madrid, Spain. Hauptthemen laut MEDLINE: Atrial Fibrillation, Amyloid Neuropathies, Familial, Cardiomyopathies. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pfizer.
Abstract (Originalsprache)
BACKGROUND: Transthyretin cardiac amyloidosis (ATTR-CA) is increasingly recognized as a treatable form of heart failure. Atrial fibrillation (AF) is common in patients with ATTR-CA. Whether recent-onset AF can be used as an early marker to identify patients with ATTR-CA has not been elucidated. METHODS: This was a prospective study conducted at 3 Spanish centres. ATTR-CA noninvasive screening was offered to patients ≥ 65 years of age recently diagnosed (< 1 year) with nonvalvular AF and who had ≥ 1 echocardiographic, electrocardiographic, or clinical sign suggestive of ATTR-CA. RESULTS: A total of 121 patients were included (75% male, mean age 77 ± 7 years). Ten patients (8.3%; 95% confidence interval [CI],4-14.7%), were diagnosed with cardiac amyloidosis (CA): 5 with definite wild-type ATTR-CA (ATTRwt), 4 with likely ATTRwt, and 1 with undetermined CA. Compared with patients without CA, patients with CA were older (84 ± 4 vs 76 ± 7 years; P < 0.001), more frequently men (90% vs 59%; P = 0.047), presented higher median N-terminal pro-B-type natriuretic peptide (NTproBNP) (3800 pg/L, interquartile range [IQR]:1682-6101 vs 1048 pg/mL, IQR: 427-3154; P = 0.017) and higher left ventricular hypertrophy (LVH) (14 mm, IQR: 13-17 vs 12 mm, IQR: 12-13; P = 0.003). Patients with CA also showed higher rate of permanent AF (90% vs 49.5%; P = 0.018) and a greater need for pacemaker implantation during follow-up (30% vs 7.3%; P = 0.049). No differences in mortality were observed between patients with and without CA after a median follow-up of 13 months (IQR: 11-16 months). CONCLUSIONS: Routine DPD scanning in elderly patients with recent-onset AF, LVH and an additional red flag may help to identify patients with ATTR-CA. However, larger studies evaluating this strategy in more diverse clinical settings would be required.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Cardiology, Hospital Universitario Puerta de Hierro Majadahonda, IDIPHISA, Madrid, Spain.
- Department of Cardiology, Hospital Universitario Virgen de la Arrixaca, Murcia, Spain.
- CIBERCV, Instituto de Salud Carlos III, Madrid, Spain; Inherited Cardiac Diseases Unit, Department of Cardiology, Instituto de Investigación Biomédica de Salamanca (IBSAL), Complejo Asistencial Universitario de Salamanc…
- Department of Nuclear Medicine, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain.
- Department of Nuclear Medicine, Hospital Universitario Puerta de Hierro Majadahonda, IDIPHISA, Madrid, Spain.
- Inherited Cardiac Diseases Unit, Department of Cardiology, Instituto de Investigación Biomédica de Salamanca (IBSAL), Complejo Asistencial Universitario de Salamanca, Gerencia Regional de Salud de Castilla y León (SACYL…
Förderung
- Pfizer
Zitieren
APA
Remior-Pérez, P., Gómez-Molina, M., García-Rodríguez, D., Gallego-Delgado, M., Mohamed-Salem, L., de Haro-Del Moral, J., Hernández-Terciado, F., de Castro, D., Eiros-Bachiller, R., Dominguez, F., Gonzalez-Lopez, E., Villacorta, E., Pascual-Figal, D. A., & Garcia-Pavia, P. (2025). Prevalence of Cardiac Amyloidosis Among Elderly Patients With Recent-Onset Atrial Fibrillation: The PREVAL-ATTR Study. Canadian Journal of Cardiology. https://doi.org/10.1016/j.cjca.2024.10.010
Vancouver
Remior-Pérez P, Gómez-Molina M, García-Rodríguez D, Gallego-Delgado M, Mohamed-Salem L, de Haro-Del Moral J, et al. Prevalence of Cardiac Amyloidosis Among Elderly Patients With Recent-Onset Atrial Fibrillation: The PREVAL-ATTR Study. Canadian Journal of Cardiology. 2025. doi:10.1016/j.cjca.2024.10.010
BibTeX
@article{RemiorPrez2025,
author = {Remior-Pérez, Paloma and Gómez-Molina, Miriam and García-Rodríguez, Daniel and Gallego-Delgado, María and Mohamed-Salem, Laroussi and de Haro-Del Moral, Javier and Hernández-Terciado, Fernando and de Castro, Daniel and Eiros-Bachiller, Rocio and Dominguez, Fernando and Gonzalez-Lopez, Esther and Villacorta, Eduardo and Pascual-Figal, Domingo A and Garcia-Pavia, Pablo},
title = {Prevalence of Cardiac Amyloidosis Among Elderly Patients With Recent-Onset Atrial Fibrillation: The PREVAL-ATTR Study},
journal = {Canadian Journal of Cardiology},
year = {2025},
doi = {10.1016/j.cjca.2024.10.010}
}
EUVIMED